Geneoscopy is a life sciences company with the mission to empower patients and providers to transform gastrointestinal health through innovative diagnostics. Geneoscopy’s lead diagnostic uses stool-derived eukaryotic RNA (seRNA) to detect colorectal cancer and precancerous adenomas. This device was awarded a Breakthrough Device Designation from the FDA for its ability to reduce morbidity associated with colorectal cancer through advanced adenoma detection. Our initial prospective clinical study demonstrates that the diagnostic can detect these lesions with greater sensitivity than all existing noninvasive screening tests, thereby, serve as a potential aid in early detection and prevention of cancer. Geneoscopy is also developing diagnostics for the diagnosis and management of inflammatory bowel disease in partnership with biopharmaceutical companies and leading academic research institutions.
View Top Employees from GeneoscopyWebsite | http://geneoscopy.com |
Revenue | $5 million |
Funding | $7 million |
Employees | 63 (56 on RocketReach) |
Founded | 2015 |
Address | 2220 Welsch Industrial Ct, St. Louis, Missouri 63108, US |
Technologies |
JavaScript,
Twitter,
Google Analytics
+13 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Genetics, Healthcare, Biotechnology, Health Care, Health Diagnostics |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies |
Looking for a particular Geneoscopy employee's phone or email?
The Geneoscopy annual revenue was $5 million in 2024.
Andrew Barnell is the Co-Founder and Chief Executive Officer of Geneoscopy.
56 people are employed at Geneoscopy.
Geneoscopy is based in St. Louis, Missouri.
The NAICS codes for Geneoscopy are [54, 5417, 54171, 541, 541714].
The SIC codes for Geneoscopy are [87, 873].